Accelerating Cell & Gene Therapy Scale-Up With An Advanced Manufacturing Platform

Manufacturing next-generation therapies is a critical challenge for cell and gene therapy developers, who often struggle to scale production while ensuring product quality and economic viability. Next-generation manufacturing technologies offer a solution to these challenges, delivering higher yields and improved operational efficiencies compared to legacy systems.

In this webinar, industry leaders from Ori Biotech and ElevateBio share how automated, scalable platforms are reshaping cell and gene therapy manufacturing. They present data demonstrating superior biological performance with these advanced platforms, showcasing how automating critical steps, integrating real-time monitoring, and decreasing variability can help you scale with confidence. Ultimately, you will learn how to accelerate your manufacturing timeline, ensuring consistent quality from early-stage development through commercial manufacturing.